Citius Pharmaceuticals, Inc. 8-K

What Happened
Citius Pharmaceuticals (CTXR) announced its results of operations for the full year of fiscal 2025 in a press release issued December 23, 2025. The company furnished that press release as Exhibit 99.1 to its Form 8‑K filed the same day (Item 2.02 – Results of Operations and Financial Condition).

Key Details

• Form 8‑K filed on December 23, 2025 (Item 2.02) announcing fiscal 2025 results.
• Press release dated December 23, 2025 is furnished as Exhibit 99.1 and incorporated by reference.
• Cover page interactive data (iXBRL) included as Exhibit 104.
• The 8‑K furnishes the press release (information provided to the public) rather than attaching standalone financial statements in the filing.

Why It Matters
This filing signals that Citius has publicly released its year‑end operating and financial results — key information for investors tracking earnings, revenue, cash position, and company progress. Retail investors should read the furnished press release (Exhibit 99.1) and any subsequent SEC filings for the detailed figures and management commentary, since those specifics drive valuation and near‑term trading reactions.